Next Generation Sequencing Panels for Hereditary Cancer

---

ONLINECancer/Oncology

Pop-up Blockers

Wednesday, May 3, 2023, 6:30 AM - Saturday, May 3, 2025, 11:00 PM


AMA PRA Category 1 Credits™ (1.00 hours), AAPA Credit(s) (1.00 hours), ANCC Contact Hour(s) (1.00 hours), General Attendance (1.00 hours), IPCE Credit(s) (1.00 hours), Non-Physician Attendance (1.00 hours)

This web-based training (WBT) module will review next generation sequencing (NGS) panels for inherited cancer risk and broadly how this information is used to help guide medical management decision-making for patients. This may include increased surveillance for cancer, chemoprevention, preventative surgical options and cancer treatment decision-making. The information in the WBT will include types of panel genetic tests, how they are performed, what the different results of genetic testing mean with respect to patient care, and what to look for when choosing a genetic testing laboratory to use. We will also review when NGS panels for hereditary cancer are appropriate to offer to patients, taking into account challenges and psychosocial factors that come into play, informed consent for this testing and when to refer to a board-certified genetic counselor. Currently, genetic testing to determine the risk for developing cancer (hereditary cancer testing) is being ordered inconsistently by health care professionals.

1. Describe different types of panel tests for hereditary cancer genetic testing.
2. Discuss the different types of results that may arise from a panel genetic test and how they may or may not impact patient care.
3. Outline some of the challenges that may arise from ordering a panel genetic test.
4. Understand when it is appropriate to refer a patient for genetic counseling.

This activity was planned by and for the healthcare team, and learners will receive 1  IPCE credits for learning and change.

Ascension adheres to ACCME Criteria, Standards and Policies regarding industry support of CE/CME. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Ascension adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

No commercial interest was received for this CE/CME activity.